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Abstract
Background: Ileal pouch-anal anastomosis (IPAA) is the surgical procedure of choice for patients with refractory
ulcerative colitis (UC) and for familial adenomatous polyposis (FAP) with many rectal polyps. Pouchitis is one of the
more frequent complications after IPAA in UC patients; however, it is rare in FAP.
Objective: Evaluate pro-apoptotic activity in endoscopically and histological normal mucosa of the ileal pouch in
patients with UC and FAP.
Methods: Eighteen patients (nine with UC and nine with FAP) with J pouch after total rectocolectomy were
studied. Biopsies were obtained from the mucosa of the pouch and from normal ileum. The specimens were snap-
frozen and the expressions of Bax and Bcl-2 were determined by immunoblot of protein extracts and by
immunohistochemistry analysis. FADD, Caspase-8, APAF-1 and Caspase-9 were evaluated by immunoprecipitation
and immunoblot.
Results: Patients with UC had significantly higher protein levels of Bax and APAF-1, Caspase-9 than patients with
FAP, but were similar to controls. The expressions of Bcl-2 and FADD, Caspase-8 were similar in the groups.
Immunohistochemistry for Bax showed less intensity of immunoreactions in FAP than in UC and Controls. Bcl-2
immunostaining was similar among the groups.
Conclusion: Patients with FAP present lower levels of pro-apoptotic proteins in all methods applied, even in the
absence of clinical and endoscopic pouchitis and dysplasia in the histological analysis. These findings may explain
a tendency of up-regulation of apoptosis in UC patients, resulting in higher rates of progression to pouchitis in
these patients, which could correlate with mucosal atrophy that occurs in inflamed tissue. However, FAP patients
had low pro-apoptotic activity in the mucosa, and it could explain the tendency to low cell turn over and
presence of adenomas in this syndrome.
Backgroud
Restorative rectocolectomy with ileal pouch and anal
anastomosis (IPAA) has become the surgical procedure
of choice for ulcerative colitis (UC) and for familial ade-
nomatous polyposis (FAP), for three decades [1-3].
Despite of its innumerous advantages over other thera-
peutic procedures, restorative retocolectomy with ileal
pouch may evolve with pouchitis, a complication that
affects up to 50% of patients with UC, and only 5% of
patients with FAP [4-6].
Although pouchitis is a commonly reported complica-
tion, its etiology remains unknown [7-11]. Due to this
difference in the incidence of pouchitis, some authors
have proposed that the reactivation of UC may have a role
in the induction of the local inflammation and in the
increased epithelial apoptosis that will, ultimately, lead to
the installation of this complication [12,13]. This hypoth-
esis is further boosted by the fact that some patients with
pouchitis have resurgence of extra-intestinal manifesta-
tions of UC in the same way as patients who have active
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UC [14,15], and by data supporting a goal for increased
apoptosis that occurs in active UC mucosa [16,17]. The
study of intrinsic and extrinsic apoptosis pathways in ileal
pouch remains not completely available and there are few
studies in the literature that have evaluated this putative
role of pouchitis etiology.
Therefore, in order to compare the apoptotic activity
in asymptomatic pouches between the highly pouchitis-
prone UC patients and the pouchitis-protected patients
with FAP we employed immunoblotting, immunopreci-
pitation assays and histological analysis to determine the
expression of pro-apoptotic and anti-apoptotic proteins,
and detection of apoptosis by Annexin V fluorescence
microscopy in ileal pouch biopsies.
Methods
Mucosal biopsies were taken from nine patients with
non-inflamed IPAA after rectocolectomy for UC [med-
ian age 48.7 (range, 31-63) years; male 44.4%; female
55.6%], and nine patients with non-inflamed IPAA after
rectocolectomy for FAP [median age 33.8 (range, 21-59)
years; male 44.4%; female 55.6%]. The follow-up after
the operation was 73.1 (24-168) months. The reservoir
design was of the “J” type in all patients, and the right
colon vascular arcade was preserved as a supplementary
blood supply to the terminal ileum [18]. Mucosectomy
was performed, with hand-sewn ileo-anal anastomosis.
The patients had had their ileostomy closed for more
than one year, at the time of the study. The absence of
pouchitis was defined clinically, histology and endosco-
pically, according to the PDAI [19]. The control group
was composed of nine individuals with normal colono-
scopy examination, with a median age of 40.9 (range, 26
- 58) years and 55.6% were female. Six biopsies of each
patient were obtained from terminal ileum (control) and
from ileal pouch (UC and FAP).
The study was performed in accordance with the
Declaration of Helsinki and was approved by the local
ethical committee. All biopsies were taken after
informed consent from the patients. The study was car-
ried out at the State University of Campinas, Coloproc-
tology Unit, and at the Cell Signaling Laboratory of the
Department of Internal Medicine.
• Immunoblotting - Gel electrophoresis
Mucosal biopsies from the pouches and from normal
ileum were snap-frozen in liquid nitrogen and stored at
-80°C until use. For total protein extract preparation,
the fragments were homogenized in solubilization buffer
at 4°C [1% Triton X-100, 100 mM Tris-HCl (pH 7.4),
100 mM sodium pyrophosphate, 100 mM sodium fluor-
ide, 10 mM EDTA, 10 mM sodium orthovanadate, 2.0
mM phenylmethylsulfonyl fluoride (PMSF), and 0.1 mg
aprotinin/ml] with a Polytron PTA 20S generator
(model PT 10/35; Brinkmann Instruments, Westbury,
NY) operated at maximum speed for 30 sec. Insoluble
material was removed by centrifugation (20 min at 9000
× g at 4°C). The protein concentrations of the superna-
tants were determined by the Bradford dye binding
method [20]. Aliquots of the resulting supernatants con-
taining 100 μg total proteins were separated by SDS-
PAGE, transferred to nitrocellulose membranes and
blotted with anti-Bax, anti-Bcl-2 antibodies [21,22]. In
immunoprecipitation experiments, samples containing
1.0 mg protein were incubated overnight with antibodies
against FADD and APAF-1. The immunocomplexes
were recovered with Protein A Sepharose, separated by
SDS-PAGE, transferred to nitrocellulose membranes,
and blotted with anti-Caspase-8 to FADD (extrinsic
pathway apoptosis), and anti-Caspase-9 to APAF-1 anti-
bodies (intrinsic pathway apoptosis) [21].
Reagents for SDS-PAGE, immunoblotting and immu-
noprecipitation were from Bio-Rad Laboratories (Rich-
mond, CA). Phenylmethylsulfonyl fluoride, aprotinin,
Triton X-100, Tween 20, glycerol were from Sigma (St.
Louis, MO). Protein A-Sepharose 6 MB was from Phar-
macia (Uppsala, Sweden), and nitrocellulose paper
(BA85, 0.2 μm) was from Amersham (Aylesbury, UK).
The anti-Bax (sc-493, rabbit polyclonal), anti-Bcl-2 (sc-
492, rabbit polyclonal), anti-FADD (sc-5559, rabbit poly-
clonal), anti-Caspase-8 (sc-7890, rabbit polyclonal), anti-
APAF-1 (sc 26685, goat polyclonal) and anti-Caspase-9
(sc-7885, rabbit polyclonal) antibodies were purchased
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
The signal was detected by chemiluminescent reaction
(SuperSignal® West Pico Chemiluminescent Substrate
from Pierce Biothecnology, Inc. Rockford).
All numerical results are expressed as the mean
± SEM of the indicated number of experiments. The
results of blots are presented as direct comparisons
of bands in autoradiographs and quantified by densito-
metry using the Gel-Pro Analyzer 3.1 software (Exon-
Intron Inc., Farrell, MD). Data were analyzed by
repeat-measure ANOVA (one-way or two-way
ANOVA) followed by analysis of significance (Tukey-
Kramer Multiple Comparisons test), comparing UC,
FAP, and control groups. The level of significance was
set at p < 0.05.
• Bax and Bcl-2 Immunohistochemistry
For immunostaining procedures, endogenous peroxidase
was blocked with 3% hydrogen peroxide/10 mM PBS
pH 6.0 for 15 min. Afterwards, the sections were micro-
waved in 3% milk buffer for 30 min and incubated over-
night with primary antibody either to Bax or Bcl-2
(DAKO A/S Denmark; A3533, rabbit polyclonal and
M0887, mouse polyclonal) applied in 1:500 and 1:150
dilution respectively at 20°C. The sections were
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incubated with post primary block and polymer second-
ary antibodies (Novocastra™ Laboratories Ltd; Novolink
RE 7260-K) for 1 h, and processed for DAB reaction,
0.5 mg/ml (Sigma, USA, St Louis). Any cell type show-
ing cytoplasmic staining was considered positive for
qualitative analysis [23,24].
Results
Patients with UC had significantly higher levels of Bax,
APAF-1 and Caspase-9 than FAP (p < 0.05), but were
similar to controls (p > 0.05). The comparison of local
levels of Bcl-2 in pouches from UC, FAP patients and
controls revealed that they were similar among the
groups (p > 0.05).
The expression of FADD and Caspase-8 was similar
among the groups (p < 0.05), however there was a ten-
dency of high levels in UC patients when compared to
other groups (p = 0.08).
The determination of proteins expressions are shown
in Figure 1.
Figure 1 Representative Western blot analyses and determination of Bax, Bcl-2, FADD - Caspase-8, APAF-1 - Caspase-9 protein
expressions in non-inflamed pouches in the Control, FAP and UC groups. For illustration purpose each line band represents one patient.
For all conditions, n = 09, *p < 0.05 vs Control; §p < 0.05 vs FAP.
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With regard to immunohistochemistry, it showed that
immunoreactivity for Bax and Bcl-2 were detected in all
groups. Bcl-2 immunostaining pattern was similar
among the groups (Figure 2).
Discussion
Pouchitis is a common complication of total rectocolect-
omy with ileal pouch-anal anastomosis [25]. The etiol-
ogy of primary pouchitis remains uncertain and several
theories have been suggested like recurrence of UC in
ileal pouch. This fact precluded the development of
appropriate prophylaxis and treatment.
The fecal stream and stasis play an important part in
the pathogenesis of immunological reactions in the ileal
pouch, but don’t explain the difference in incidence of
pouchitis in UC and FAP patients. There were immuno-
logical changes in the pouch for at least one year after
ileostomy closure in adaptation way after this surgery
[26]. Our patients in this study had more than 1 yr of
follow-up after ileostomy closure, in order to evaluate
Figure 2 Immunohistochemistry of ileal pouch sections from UC, FAP and control group immunoreacted for Bax and Bcl-2.
Immunostainig for Bax was intense in UC group. Bcl-2 positive cell among the groups was similar. (200×)
Leal et al. Journal of Translational Medicine 2010, 8:11
http://www.translational-medicine.com/content/8/1/11
Page 4 of 6
apoptosis activity that could lead to pouchitis after this
transitional period.
Several cytokines have been reported in ileal pouches,
showing that pro-inflammatory cytokines like TNF-a,
IL-1b, IL-6, IL-8, IFN-g are elevated in UC patients, but
poorly studied in FAP [4,27-30].
The inflammatory and apoptosis pathways are linked
and some pro-inflammatory cytokines, such TNF-a, are
evolved in regulation of cell apoptosis. The elevated
expression of Fas-Fas-L (CD95-CD95L), a pro-apoptotic
member of the TNF-superfamily, has been reported in
ileal pouches of patients with UC and a history of pou-
chitis, but it wasn’t compared to FAP patients. It has
been related to the role of increased epithelial turn over
in the etiology of pouchitis [12]. Indeed, another study
reported higher expression of Bad, a potent pro-apopto-
tic protein of Bcl-2 family, in ileal pouch of UC patients
when compared to FAP [13].
This study, we evaluated the expression of pro-apop-
totic and anti-apoptotic proteins of Bcl-2 [31,32] and
Caspases [33,34] families to evaluate intrinsic and
extrinsic pathways of apoptosis in normal ileal pouches.
Even in such optimal clinical, endoscopic and histologi-
cal conditions, the local levels of pro-apoptotics proteins
were high in UC patients. Bax, APAF-1 and Caspase-9
expressions were very higher, and FADD, Caspase-8
expressions had a discrete tendency to be more intense
in UC patients when compared to FAP. This fact is
extremely interesting showing that there is an up-regu-
lating of apoptosis in UC, which could lead or correlate
with inflammation tendency in these pouches. It could
be due to the fact that both inflammatory and apoptosis
pathways are related.
Furthermore, the major pathway of apoptosis in
these cases were intrinsic mitochondrial pathway char-
acterized by APAF-1 and Caspase-9 expressions, and it
is by according to higher levels of Bad, a member of
Bcl-2 family that stays in the mitochondrial mem-
brane, verified in ileal pouches of UC patients in
another study [13]. With regard to similar Bcl-2
expression in the different groups, it could mean that
all patients were asymptomatic with normal endo-
scopic and histological features, so there is a balance
between pro and anti-apoptotic activities. The
increased apoptosis plays an important role in the
pathogenesis of pouchitis and probably not a defective
of down-regulation promoted by anti-apoptotic pro-
teins. These results were emphasized by results of Bax
and Bcl-2 immunohistochemistry.
In the other side, FAP had less expression of pro-
apoptotic proteins, thus minor potential cell turn over
and it might have a tight connection with primary dis-
ease in these patients. Some authors have been reported
adenomas in ileal pouch of FAP, more commonly than
in UC patients, who have more inflammatory polyps
[35-38]. It could be due to low cell turn over that occurs
in FAP ileal pouches.
The importance in knowing of the pathways of cell
apoptosis in ileal pouch can lead us to understand more
about molecular biology involved in pouchitis, and in
the primary diseases, FAP and UC.
Conclusions
In summary, the present study shows that, even under
non-inflammatory conditions, patients with UC present
higher levels of pro-apoptotic protein in the normal
mucosa of pouches. The higher pro-inflammatory cyto-
kines expression in UC, when compared with FAP, veri-
fied in the literature, suggests that primary defects of
macrophage-lymphocyte regulation, which may coincide
with defective regulation of apoptosis, showed in this
study, playing an important role in the development of
local inflammation in this group of patients. Moreover,
we showed a defective regulation of apoptosis in the
mucosa of FAP pouches.
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